School of Medicine
Showing 791-800 of 929 Results
-
Simon Conti
Clinical Associate Professor, Urology
BioI am a founding member of the Stanford Urolithiasis Project, where we have studied population health datasets to examine surgical outcomes and environmental risk factors in urinary stone disease. Our current focus includes socioeconomic and ethnic disparities in kidney stone disease, water quality and stone disease, pregnancy in kidney stone disease and geographical variations in kidney stones incidence and metabolic kidney stone work up.
-
Marimar Contreras Nieves
Clinical Scholar, Medicine - Nephrology
Postdoctoral Scholar, NephrologyBioI am currently in my second year of nephrology fellowship, working on a Masters in clinical research and epidemiology, and also doing postdoctoral research on a U2C-TL1. During my training I have worked on clinical research focused on environmental risk factors and health care barriers that can initiate or accelerate the development and progression of kidney disease. My goal is to reach disadvantaged populations and help reduce the gaps in health that may stem from their vulnerability to determinantal environmental exposures. My projects have included investigating chronic kidney disease of uncertain etiology, with particular interest in California’s Central Valley.
-
Alexander Patricio Conway
Clinical Assistant Professor, Medicine
BioAlexander P. Conway, MD is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine. He received his medical degree from Washington University School of Medicine in St. Louis and completed his residency in Internal Medicine at the University of California, San Francisco. Dr. Conway’s clinical interests include inpatient oncology and the care of medically complex hospitalized patients with cancer. His academic interests focus on gastrointestinal oncology, with an emphasis on hepatobiliary malignancies, metabolic dysfunction-associated steatotic liver disease (MASLD), and the development of novel cancer therapeutics.
